KAYS Stock — Kaya Holdings Inc

Kaya Holdings Inc (KAYS)

Updated October 15, 2026.

KAYS is a Stock. Its deepest 1-year drawdown was 99.8%.

Kaya Holdings is a vertically integrated cannabis enterprise that produces, distributes, and sells cannabis products including flower, oils, vape cartridges, and infused edibles and beverages through retail outlets under the Kaya Shack brand, while also operating psychedelic treatment clinics under The Sacred Mushroom name offering psilocybin treatments in Portland, Oregon. The company does not currently distribute to shareholders. This business appeals primarily to investors seeking exposure to the legal cannabis and emerging psychedelic treatment sectors rather than income-focused investors.

KAYS performance

Returns are updating. KAYS's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 99.8%.

KAYS key facts

Asset type

Stock

Asset class

Equity

Inception date

01/07/1999

Distribution frequency

None

Last close

$0.0013 (as of 2026-10-15)

Market cap

$892,363

Average volume

0.0

Payment date

12/15/2020

Beta

0.534

Payout ratio

0.0%

EPS

$-0.10

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

KAYS risks and drawbacks

The deepest 1-year drawdown on record here is 99.8%.

Who may consider KAYS — and who may not

It is a weaker fit for investors who need monthly cash flow (KAYS does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on KAYS

• All tickers starting with K

Tagged: Healthcare.

Frequently asked questions